Johnson & Johnson Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (195)

Latest Posts

About This Stock More About This Stock
The Biggest S&P 500 Firms Grow Bigger
Article By: Ironman
Thursday, August 6, 2020 4:05 AM EDT
Eight firms have consistently ranked in the Top 10 by market capitalization within the S&P 500 during 2020, growing from representing one-fifth of the index' total market cap to nearly one quarter during the first seven months of 2020.
In this article: BRK-B, JNJ, AAPL, AMZN, GOOG, MSFT, FB, GOOGL
Read
The Trump Effect: How Trump's Policies Moved Stocks This Past Week
Article By: The Fly
Sunday, August 2, 2020 8:45 AM EDT
Trump says drug prices to be "lowered massively," Chinese-backed hackers reportedly behind Moderna attack.
In this article: L, AZN, BMY, GSK, JNJ, LLY, MRK, NVS, PFE, SNY, RHHBY, AAPL, AMZN, GOOG, MSFT, MRNA, SNAP, FB, TWTR, GOOGL, KODK
Read
E Johnson & Johnson: Recession-Proof Dividend Growth
Article By: SureDividend
Tuesday, July 28, 2020 12:36 PM EDT
Johnson & Johnson is a legendary dividend growth stock. It should continue to raise its dividend even in a severe recession.
In this article: JNJ
Read
Ten Best And Worst Performing Biotech Stocks Amid Covid-19
Article By: ValueWalk
Monday, July 20, 2020 12:00 PM EDT
Here we take a look at the top ten best and worst performing biotech stocks this year. Novavax is up more than 2000% YTD.
In this article: GSK, VRTX, MRK, NVS, BMY, BIO, JNJ
Read
Johnson & Johnson CFO On Q2 Earnings, Raising Guidance, Covid-19 And More
Video By: CNBC
Thursday, July 16, 2020 9:38 AM EDT
Johnson & Johnson beats Q2 earnings expectations on top and bottom lines.
In this video: JNJ
Watch

PARTNER HEADLINES

Latest Tweets for $JNJ

No tweets yet!

$JNJ

How To Invest In Woman-Led Companies With ETFs & Stocks
Financial Zonked Talk 4/9/2019 4:45:28 AM

Not until they remove cancer causing $JNJ from portfolio.

Johnson & Johnson: Recession Safety, Growth And Valuation
Stuart Saunders 10/1/2018 2:44:49 AM

Inventors, do not trust johnson and Johnson $JNJ

Johnson & Johnson Upgraded To Neutral From Sell At Goldman Sachs
Bill Myers 7/12/2018 12:37:26 PM

Still not impressed with $JNJ.

1 to 3 of 3 comments